2',3',5'-Tri-O-acetyl-D-adenosine

2',3',5'-Tri-O-acetyl-D-adenosine

Chemical Name

[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methyl acetate

2',3',5'-Tri-O-acetyl-D-adenosineHeterocyclic Compound
Structure: 2',3',5'-Tri-O-acetyl-D-adenosine structure, CAS 7387-57-7, MW 393.35
Product No
CH58005
CAS
7387-57-7
MF
C16H19N5O7
MW
393.35
Specification
Catalog No.CH58005
CAS No.7387-57-7
Molecular FormulaC16H19N5O7
Molecular Weight393.35

CHEMOS Support for This Category

CHEMOS supports heterocyclic building-block synthesis for medicinal chemistry, discovery chemistry, and process-development programs. Diverse heterocycles : substituted 5-, 6-, and 7-membered N/O/S heterocyclic intermediates. Custom synthesis : route design from substituted precursors or suitable starting materials. Cross-coupling chemistry : C-N, C-C, C-O, and related bond-forming steps can be evaluated by substrate. Route optimization : impurity control, purification strategy, and robust reaction-condition screening. Scale-up support : batch-size planning after feasibility and safety review.

Overview

2',3',5'-Tri-O-acetyl-D-adenosine (also known as [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methyl acetate) (CAS 7387-57-7, MF C16H19N5O7, MW 393.35) is a heterocyclic organic building block used in medicinal chemistry and process research. Chemistry topics typically cover regioselective substitution on the heterocyclic core, scalable preparation, and impurity / regio-isomer control. Custom synthesis, process scale-up and supply planning are available through CHEMOS R&D and manufacturing facilities.

Applications

  • 2',3',5'-Tri-O-acetyl-D-adenosine (CAS 7387-57-7) preparation, route refinement, and analytical-control planning
  • Fragment library and SAR exploration in drug-discovery research
  • Cross-coupling substrate (Suzuki, Buchwald-Hartwig, C-H activation)
  • Custom synthesis of substituted heterocyclic analogs

Need Custom Synthesis?

Our CDMO team provides end-to-end custom synthesis support from discovery through process development and scale-up.

Explore CDMO Services